Simultaneous defeat of MCF7 and MDA-MB-231 resistances by a hypericin PDT-tamoxifen hybrid therapy.
Theodossiou TA, Ali M, Grigalavicius M, Grallert B, Dillard P, Schink KO, Olsen CE, Wälchli S, Inderberg EM, Kubin A, Peng Q, Berg K.
Theodossiou TA, et al.
NPJ Breast Cancer. 2019 Apr 10;5:13. doi: 10.1038/s41523-019-0108-8. eCollection 2019.
NPJ Breast Cancer. 2019.
PMID: 30993194
Free PMC article.